Willet F. Jr. Whitmore

Willet F. Jr. Whitmore's AcademicInfluence.com Rankings

Philosophy

#2437

World Rank

#4170

Historical Rank

Logic

#585

World Rank

#1049

Historical Rank

philosophy Degrees

Willet F. Jr. Whitmore

Biology

#2812

World Rank

#4400

Historical Rank

Biochemistry

#242

World Rank

#302

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Willet F. Jr. Whitmore's Degrees

Doctorate Medicine Harvard University
PhD Biochemistry Stanford University

Why Is Willet F. Jr. Whitmore Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Willet F. Jr. Whitmore's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse (1989) (677)
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. (1991) (448)
Effects of combined drug therapy on metastatic cancer of the testis. (1960) (362)
Solitary metastasis from renal cell carcinoma. (1975) (296)
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. (1995) (284)
Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. (1983) (281)
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. (1984) (273)
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. (1988) (271)
The response of metastatic adenocarcinoma of the prostate to exogenous testosterone. (1981) (260)
Epidemiology of cancer of the prostate (1971) (260)
Improvement of Cis‐dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model (1977) (253)
Hormone therapy in prostatic cancer. (1956) (246)
Radical total cystectomy for cancer of the bladder:230 consecutive cases five years later. (1962) (245)
Penile cancer: relation of extent of nodal metastasis to survival. (1987) (241)
Intermittent endocrine therapy for advanced prostate cancer (1986) (229)
Retropubic implantation to iodine 125 in the treatment of prostatic cancer. (1972) (228)
Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. (1986) (228)
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. (1989) (226)
Regional lymph node metastasis from bladder cancer. (1981) (218)
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. (1987) (208)
The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma (1987) (203)
Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. (1977) (197)
Autopsy findings in 154 patients with germ cell tumors of the testis (1982) (196)
An overview of intravesical therapy for superficial bladder tumors. (1987) (188)
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. (1986) (183)
Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. (1977) (183)
Natural history and staging of prostate cancer. (1984) (175)
Expectant management of localized prostatic cancer (1991) (170)
The evolution of mature teratoma from malignant testicular tumors (1977) (167)
Primary carcinoma of the ureter: A prognostic study (1975) (164)
Complications of ureteroileal conduit with radical cystectomy: review of 336 cases. (1980) (162)
The natural history of prostatic cancer (1973) (160)
Renal pelvic tumors. (1971) (157)
Cell surface antigens of human renal cancer defined by autologous typing (1979) (157)
Epidemiology of adenocarcinoma of the kidney. (1974) (156)
Endoscopic diagnosis and treatment of upper‐tract urothelial tumors. A preliminary report (1985) (156)
Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy (1984) (154)
Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. (1997) (148)
Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. (1981) (148)
Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. (1976) (146)
Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. (1977) (145)
Flow cytometry of prostate cancer: relationship of DNA content to survival. (1987) (139)
Primary mediastinal germ cell tumors (1974) (137)
Effect of intravesical bacillus calmette‐guerin (BCG) on carcinoma in situ of the bladder (1983) (133)
Testicular cancer in cryptorchids (1982) (127)
VAB-6 combination chemotherapy in disseminated cancer of the testis. (1981) (126)
Detection and follow‐up of carcinoma of the urinary bladder by flow cytometry (1982) (126)
The rationale and results of ablative surgery for prostatic cancer (1963) (125)
Cis-dichlorodiammineplatinum(II) in advanced bladder cancer. (1976) (124)
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. (1987) (123)
The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate (1953) (121)
A report of the workshops on the current status of the histologic grading of prostate cancer (1979) (120)
Cryptorchidism and testicular cancer. (1980) (119)
A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer (1977) (117)
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors. (1985) (117)
Fibrinolysis in metastatic cancer of the prostate (1952) (116)
The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer (1981) (114)
Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. (1998) (114)
Carcinoma of the bladder. (1953) (112)
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. (1985) (110)
Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. (1979) (104)
Combined chemotherapy and surgery in treatment of advanced germ‐cell tumors (1981) (104)
Reconstruction of the urinary tract by cecal and ileocecal cystoplasty: review of a 15-year experience. (1983) (103)
The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma (1987) (100)
Behavioral patterns of prostate adenocarcinoma following an 125I implant and pelvic node dissection. (1977) (98)
A critical analysis of response criteria in patients with prostatic cancer treated with CIS‐diamminedichloride platinum II (1979) (98)
Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. (1987) (98)
Toxicity of intravesical BCG and its management in patients with superficial bladder tumors (1987) (95)
The role of neoadjuvant hormonal manipulation in localized prostatic cancer (1993) (92)
Papilloma of the urinary bladder (1970) (91)
Surgical treatment of spinal cord compression in kidney cancer. (1986) (91)
Myosarcomas of the bladder and prostate (1968) (90)
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. (1990) (89)
Malignant lymphoma of the testis: a clinicopathologic study of 37 cases. (1977) (89)
Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial. (1985) (88)
Cancer of the female urethra. (1966) (87)
Primary signet-ring cell carcinoma of urinary bladder. (1989) (87)
Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin (1976) (87)
Methotrexate: An active drug in bladder cancer (1981) (87)
Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate. (1953) (86)
The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. (1994) (85)
VAB–4 combination chemotherapy in the treatment of metastatic testis tumors (1981) (85)
Radiation therapy and pelvic node dissection in the management of cancer of the prostate. (1974) (84)
125I implantation for carcinoma of prostate. Further follow-up of first 100 cases. (1982) (84)
Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. (1987) (83)
Localised prostatic cancer: management and detection issues (1994) (83)
Gleason grading of prostate cancer: a predictor of survival. (1985) (82)
Modeling the development of metastases from primary and locally recurrent tumors: comparison with a clinical data base for prostatic cancer. (1993) (82)
Cytohistological observations on developing carcinoma of the urinary bladder in man (1960) (82)
Experiences with various operative procedures for the total excision of prostatic cancer (1959) (82)
Malignant tumors of the spermatic cord (1969) (82)
An improved method for computerized tomography-planned transperineal 125iodine prostate implants. (1991) (81)
Recent results of management of palpable clinically localized prostate cancer (1993) (81)
Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid (1980) (81)
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The memorial sloan‐kettering cancer center experience (1994) (80)
Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management. (1987) (80)
Experience with primary carcinoma of the male urethra. (1977) (80)
Adriamycin in advanced urinary tract cancer. Experience in 42 patients and review of the literature (1977) (79)
Natural history of low-stage prostatic cancer and the impact of early detection. (1990) (79)
Flow cytometry in bladder cancer detection and evaluation using acridine orange metachromatic nucleic acid staining of irrigation cytology specimens. (1980) (78)
Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors (1986) (76)
Integrated irradiation and cystectomy for bladder cancer. (1980) (76)
The effect of flutamide on testosterone metabolism and the plasma levels of androgens and gonadotropins. (1977) (74)
Preoperative irradiation with cystectomy in the management of bladder cancer. (1968) (74)
Spermatic cord sarcoma in adults. (1978) (73)
Flow cytometry of low stage bladder tumors: Correlation with cytologic and cystoscopic diagnosis (1982) (73)
Embryonal adenocarcinoma in the prepubertal testis. A Clinicopathologic Study of 18 Cases (1970) (73)
The concentration of zinc in diseased human prostate glands (1964) (73)
Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. (1985) (72)
Combination therapy of urogenital embryonal rhabdomyosarcoma in children (1973) (72)
Experience with flutamide in previously untreated patients with advanced prostatic cancer. (1979) (72)
Considerations for the use of testosterone with systemic chemotherapy in prostatic cancer (1982) (71)
Advanced seminoma: the role of chemotherapy and adjunctive surgery. (1988) (68)
Renal tumors: pathology and prognosis in 295 cases. (1951) (68)
VAB‐3 combination chemotherapy of metastatic testicular cancer (1981) (67)
Experience with carcinoma of the scrotum. (1977) (67)
In situ carcinoma of the prostate with intraepithelial extension into the urethra and bladder. A Paget's disease of the urethra and bladder (1953) (67)
VAB‐6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis (1983) (67)
Lymphocele after pelvic lymphadenectomy for urologic cancer. (1981) (66)
Carcinoma in‐situ of the ureter in patients with bladder carcinoma treated by cystectomy (1970) (66)
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors. (1987) (65)
Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. (1984) (65)
Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra. (1989) (65)
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. (1984) (65)
The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982). (1985) (64)
The treatment of extragonadal seminoma. (1984) (62)
Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. (1989) (60)
Sarcomas of the kidney. (1984) (60)
Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer (1978) (58)
The Preparation of Unsaturated Sulfones by Condensation Reactions1 (1950) (58)
Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics. (1986) (58)
Human and mouse embryonal carcinoma cells in culture share an embryonic antigen (F9) (1977) (57)
Lymphocyte Stimulation: Selective Destruction of Cells during Blastogenic Response to Transplantation Antigens (1971) (57)
Effects of certain metals and chelating agents on rat and dog epididymal spermatozoan motility. (1967) (56)
Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience. (1983) (56)
Salvage cystectomy for bladder cancer after failure of definitive irradiation. (1981) (56)
Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer. (1995) (54)
Management of clinically localized prostatic cancer. An unresolved problem. (1993) (54)
VAB-6 as initial treatment of patients with advanced seminoma. (1985) (53)
The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin. (1990) (53)
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors. (1985) (53)
The effect of bilateral adrenalectomy upon neoplastic disease in man (1952) (53)
Preoperative irradiation and cystectomy for bladder cancer (1982) (52)
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. (1988) (52)
Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment. (1975) (52)
An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder (1982) (51)
Interstitial radiation therapy for carcinoma of the prostate (1980) (51)
Renal cell carcinoma extending into inferior vena cava. (1983) (51)
Radical surgery for carcinoma of the urinary bladder. One hundred consecutive cases four years later (1956) (51)
Simple total cystectomy for carcinoma of the urinary bladder. One hundred fifty‐six consecutive cases five years later (1956) (50)
Management of bladder cancer. (1979) (50)
125iodine reimplantation for locally progressive prostatic carcinoma. (1990) (50)
SOME EXPERIENCES WITH RETROPERITONEAL LYMPH NODE DISSECTION AND CHEMOTHERAPY IN THE MANAGEMENT OF TESTIS NEOPLASMS (1962) (49)
Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: Relation to therapeutic response (1982) (49)
Flow cytometric evaluation of sperm from patients with testicular carcinoma. (1984) (48)
Extended total excision of prostatic adenocarcinoma. (1978) (47)
Immunohistologic dissection of the human kidney using monoclonal antibodies. (1985) (46)
Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors. (1983) (46)
Recent result of managment of palpable clinically localized prostate cancer (1993) (46)
The role of germinal epithelium and spermatogenesis in the privileged survival of intratesticular grafts. (1985) (45)
Seminal fluid and spermatozoon zinc levels and their relationship to human spermatozoon motility. (1971) (45)
Phase II trial of doxorubicin in bidimensionally measurable prostatic adenocarcinoma. (1984) (45)
Some observations on the distribution of radioactive zinc in prostatic and other human tissues. (1956) (45)
Experimental studies on the radiation‐modifying effect of cis‐diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice (1983) (45)
Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery. (1990) (45)
Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate. (1982) (45)
Bladder tumors in children. (1973) (44)
Expectant management of clinically localized prostatic cancer. (1994) (43)
Implantation of 125I in prostatic cancer. (1974) (43)
Significance of prostatic biopsies after radiation therapy for carcinoma of the prostate (1982) (42)
The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience. (1988) (41)
Monitoring intravesical bacillus Calmette‐Guerin treatment of superficial bladder carcinoma by serial flow cytometry (1986) (40)
Cancer of the undescended or maldescended testis. (1976) (40)
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma. (1987) (40)
Intravesical cisplatin for superficial bladder tumors (1982) (40)
Clinical and metabolic studies of bilateral adrenalectomy for advanced cancer in man. (1953) (39)
125I Implantation of the Prostate: Dose-Response Considerations (1978) (38)
Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor (1981) (37)
Ureteral carcinoma in situ. (1975) (37)
The treatment of bladder tumors. (1969) (37)
Recurrences in surgical stage I nonseminomatous germ cell tumors of the testis. (1983) (37)
Adjuvant chemotherapy with VAB‐3 of stage II‐B testicular cancer (1981) (37)
Patterns of recurrence in bladder cancer treated by irradiation and/or cystectomy. (1978) (36)
Leukemoid reaction, thrombocytosis and hypercalcemia associated with bladder cancer. (1973) (36)
Identification of polymorphonuclear leukocytes in cytologic samples for flow cytometry. (1979) (36)
Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β‐glucuronidase activity (1976) (35)
Leiomyosarcoma of the renal pelvis. (1973) (35)
Sequential bilateral germ cell tumors of the testis despite interval chemotherapy. (1979) (35)
Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms (1976) (35)
A technique for the extension of radical surgery in the treatment of vesical cancer (1949) (35)
Factors of prognostic and therapeutic significance in patients with bladder cancer. (1981) (34)
HLA antigens in patients with germ cell cancers of the testis. (1982) (34)
Radiation therapy in adenocarcinoma of the prostate with pelvic lymph node involvement on lymphadenectomy. (1978) (34)
Randomized trial of standard therapy with or without poly I:C in patients with superficial bladder cancer (1981) (34)
Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery (1984) (32)
Management of invasive bladder neoplasms. (1983) (32)
Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin. (1989) (32)
Ultraviolet cystoscopy in patients with bladder cancer. (1966) (32)
Relationship of pretreatment transurethral resection of the prostate to survival without distant metastases in patients treated with 125I‐implantation for localized prostatic cancer (1984) (32)
Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. (1977) (32)
The influence of simultaneous resection of bladder tumors and prostate on the occurrence of prostatic urethral tumors. (1981) (32)
Adriamycin and cyclophosphamide in advanced bladder cancer. (1977) (32)
Prognostic significance of regional lymph node histology in cancer of the bladder. (1976) (32)
Carcinoma in situ of bladder: clinico-pathologic study of case with a suggested approach to detection. (1966) (31)
The surgical treatment of cancers of the urinary bladder (1956) (31)
VAB‐5 combination chemotherapy in prognostically poor risk patients with germ cell tumors (1983) (31)
Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture. (1976) (31)
Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumors of testis (1985) (31)
Urethral cytology following cystectomy for bladder carcinoma (1977) (30)
Urethral meatal carcinoma following cystourethrectomy for bladder carcinoma. (1976) (30)
Hemorrhagic diathesis in patients with carcinoma of prostate. (1956) (30)
Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. (1984) (30)
Carboplatin, etoposide, and bleomycin for patients with poor‐risk germ cell tumors (1990) (29)
VP‐16–213 and cisplatin in the treatment of patients with refractory germ cell tumors (1984) (29)
Planned preoperative cisplatin and radiation therapy for locally advanced bladder cancer (1983) (29)
Flow cytometry for followup examinations of conservatively treated low stage bladder tumors. (1981) (29)
TREATMENT OF BLADDER TUMORS BY INSTILLATION OF THIO-TEPA, ACTINOMYCIN D, OR 5-FLUOROURACIL. (1965) (29)
Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma. (1988) (29)
Interstitial radiation: short-term palliation or curative therapy? (1985) (29)
Flow cytometry followup of patients with low stage bladder tumors. (1982) (28)
Status of integrated irradiation and cystectomy for bladder cancer. (1984) (28)
Hormone-secreting metastatic interstitial cell tumor of the testis. (1989) (27)
Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry. (1985) (27)
Unusual malignant tumors of the scrotum: review of 5 cases. (1972) (27)
Radioactive zinc in the prostate; some factors influencing concentrations in dogs and men. (1959) (27)
Tetracycline ultraviolet fluorescence in bladder carcinoma (1964) (27)
Intratesticular germ cell tumors: observations on the effect of chemotherapy. (1981) (27)
Studies on the prostate and testis as immunologically privileged sites. (1977) (27)
Bladder cancer: An overview (1988) (26)
Experience with anteromedian (12 o'clock) external urethral sphincterotomy in 100 male subjects with neuropathic bladders. (1978) (26)
EXPERIENCE WITH PREOPERATIVE IRRADIATION FOLLOWED BY RADICAL CYSTECTOMY FOR THE TREATMENT OF BLADDER CANCER. (1963) (26)
Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG. (1989) (26)
Zinc content of spermatozoa from various levels of canine and rat reproductive tracts. (1967) (25)
Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. (1987) (25)
Cryosurgery in the treatment of bone metastases from renal cell carcinoma. (1977) (25)
Presumptive downstaging from preoperative irradiation for bladder cancer as determined by flow cytometry: preliminary report. (1983) (25)
Retropubic implantation of iodine 125 in the treatment of prostatic cancer. (1972) (25)
Zinc uptake in canine or rat spermatozoa. (1969) (25)
Inguinal lymph node metastases from germ cell testicular tumors. (1984) (25)
Adjuvant chemotherapy in resected nonseminomatous germ cell tumors of testis: stages I and II. (1979) (25)
Intratubular malignant germ cells (carcinoma in situ) accompanying invasive testicular germ cell tumors. (1985) (25)
Impact of symptomatic interval on prognosis of patients with stage III testicular cancer. (1983) (25)
Automated flow cytometry to monitor intravesical BCG therapy of superficial bladder cancer. (1981) (25)
Non‐extirpative treatment of myosarcomas of the bladder and prostate (1971) (24)
Effect of flutamide on cortisol metabolism. (1978) (24)
Potentiation of methylglyoxal‐bis‐guanylhydrazone by alpha‐difluoromethylornithine in rat prostate cancer (1984) (24)
Inferior pubic rami resection with en bloc radical excision for invasive proximal urethral carcinoma (1983) (24)
Plasma lipid bound sialic acid in patients with prostate and bladder cancer. (1981) (24)
Mithramycin in metastatic urogenital cancer. (1967) (24)
Second primary germ cell tumors in patients with seminoma of the testis. (1983) (23)
Carcinoma of the prostate: treatment with pelvic lymphadenectomy and iodine-125 implants. (1979) (23)
Poorly differentiated (anaplastic) seminoma of the testis (1984) (23)
Staging and surgery in testicular cancer. (1981) (23)
Review of an 8-year experience with modifications of endoscopic suspension of the bladder neck for female stress urinary incontinence. (1990) (23)
Radiocolloid scintigraphic mapping of the lymphatic drainage of the prostate. (1980) (23)
Synthesis and body distribution of alpha-aminoisobutyric acid-L-11C in normal and prostate cancer-bearing rat after chemotherapy (2004) (23)
Resection of pubic rami for urologic cancer. (1968) (22)
The microscopic identification of the elements of the platinum group and gold (1935) (22)
Preoperative whole pelvis verus true pelvis irradiation and/or cystectomy for bladder cancer. (1981) (22)
Segmental replacement of the ureter using tapered and nontapered ileum. (1981) (22)
New staging systems for prostate cancer. (1989) (22)
Identification of testosterone in human spermatic vein blood. (1957) (22)
Metallic Soaps—Their Uses, Preparation, and Properties (1930) (21)
Characterization of bladder papilloma by two-parameter DNA-RNA flow cytometry. (1982) (21)
Visualization of canine and human prostatic lymph nodes following intraprostatic injection of technetium-99m-antimony sulfide colloid. (1980) (21)
TNM staging of testis cancer. (1980) (21)
Some effects of dithizone on the canine prostate (1960) (21)
Estrogen, progesterone, and androgen‐binding sites in renal cell carcinoma. Observations obtained in phase II trial of flutamide (1984) (20)
Cytologic diagnosis of metastatic germ-cell tumors. (1983) (20)
Serum prostatic acid‐phosphatase levels in the male patients of a cancer‐prevention clinic (1956) (20)
The effects of prostatic surgery on the level of serum acid glycerophosphatase. (1955) (20)
Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer. (1983) (20)
Estimation of ABO(H) isoantigen expression in bladder tumors. (1985) (20)
Hemipelvectomy for advanced penile cancer. (1973) (20)
Influence of Castration and Sex Hormones on Size, Histology and Zinc Content of Canine Prostate (1963) (20)
'Local recurrence' and 'disease-free survival'. Doubtful parameters when comparing non-randomized studies of prostate cancer. (1991) (20)
Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer. (1982) (19)
Physiological effects of bilateral adrenalectomy in man (1952) (19)
Nature and Constitution of Shellac IPreliminary Investigation of the Action of Organic Solvents (1929) (19)
Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors. (1983) (19)
Interrelationships of histopathology and other clinical variables in patients with germ cell tumors of the testis (1983) (19)
Adjuvant chemotherapy in non-seminomatous testis cancer: "mini-VAB" regimen: long-term followup. (1981) (18)
The VAB‐6 regimen in the treatment of metastatic seminoma (1984) (18)
Testicular failure in patients with extragonadal germ cell tumors (1987) (18)
The Preparation of Alpha and Beta Indanol and Some of Their Derivatives from Indene1,2 (1942) (18)
The occurrence of intravenously injected radioactive zinc in the prostate and prostatic fluid of dogs. (1957) (18)
Role of chemotherapy and surgery in the treatment of thoracic metastases from nonseminomatous germ cell testis tumor (1982) (18)
Chemotherapy of seminoma. (1977) (18)
Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program. (1982) (18)
Cytoreductive surgery for advanced nonseminomatous germ cell tumors of testis. (1982) (18)
Monitoring endoscopic treatment of superficial bladder carcinoma by postoperative urinary cytology. (1987) (18)
Urological presentations of nonHodgkin's lymphomas. (1982) (17)
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder. (1985) (17)
Discouraging results for high dose external beam radiation therapy in low stage (O and A) bladder cancer. (1982) (17)
Simple Cystectomy for Cancer of the Urinary Bladder One Hundred Consecutive Cases: two Years Later1 (1950) (17)
The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease. (1977) (17)
Ureteroileal anastomotic leaks: percutaneous treatment. (1983) (17)
Serum prostatic acid‐phosphatase levels in proved cases of carcinoma or benign hypertrophy of the prostate (1956) (17)
Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). (1988) (17)
Results of bilateral adrenalectomy in the management of incurable breast cancer. Report of 155 cases (1959) (16)
Osteitis pubis treated with adreno corticotrophic hormone. (1952) (16)
Effect of flutamide on estradiol metabolism. (1979) (16)
Bilateral adrenalectomy in the palliation of metastatic breast cancer (1957) (16)
Interstitial Irradiation in Prostatic Cancer: Report of 10-Year Results (1987) (16)
TETRACYCLINE ULTRAVIOLET FLUORESCENCE IN BLADDER CARCINOMA. (1964) (16)
Identification of Certain Solvents by the Xanthate Reaction: Application to Alcohols (1935) (16)
Cancer of the urogenital tract: bladder cancer. Combined radiotherapy and surgical treatment. (1969) (16)
Frozen section lymph node analysis in pelvic lymphadenectomy for prostate cancer. (1988) (15)
Therapy and prognosis of testicular carcinomas in relation to TNM classification. (1982) (15)
Supervoltage X‐ray therapy of bladder cancer (1965) (15)
Proceedings: The natural history of prostatic cancer. (1973) (15)
Toward the rational management of bladder cancer: an overview. (1988) (15)
Solitary vaginal metastasis from unsuspected renal cell carcinoma. (1979) (15)
Detection of carcinoma in the post-cystectomy urethral remnant by flow cytometric analysis. (1988) (15)
The comparative medical costs of 2 major procedures available for the treatment of stress urinary incontinence. (1982) (15)
Cell-cycle distribution of urothelial tumour cells as measured by flow cytometry. (1979) (15)
VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis. (1983) (14)
The practical use of tumor marker determination in bladder washing specimens. Assessing the urothelium of patients with superficial bladder cancer (1987) (14)
Unresectable carcinoma of the bladder (1983) (14)
Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder. (1978) (14)
The use of progesterone in treatment of cancer of the prostate. (1951) (14)
Carcinoma of prostate presenting as retroperitoneal mass. (1978) (14)
Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer. (1990) (14)
Some effects of freezing the rat kidney in situ. (1964) (14)
Correlation of serum tumor markers and lymphangiography with degrees of nodal involvement in surgical stage II testis cancer. (1982) (14)
Study of local and systemic effects of intravesical BCG. (1975) (14)
Conservative Management of Localized Prostatic Cancer (1992) (14)
The Preparation of Homophthalyl Cyclic Hydrazide and 4-Aminohomophthalyl Cyclic Hydrazide (1944) (14)
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection. (1986) (13)
Bladder papilloma: therapeutic and cost effect of outpatient department management. (1981) (13)
Local control is associated with decreased distant failure in early stage carcinoma of the prostate (1989) (13)
Surgical treatment of adult germinal testis tumors. (1979) (13)
Fibrinolytic activity in human prostatic fluid and semen. (1956) (13)
Intratesticular grafts: the testis as an exceptional immunologically privileged site. (1978) (12)
VAB‐6 combination chemotherapy in resected stage II‐B testis cancer (1983) (12)
The present position of radical cystectomy in the surgical management of carcinoma of the urinary bladder. (1956) (12)
Assessment and management of deeply invasive and metastatic lesions. (1977) (12)
Experience with interstitial implantation of iodine 125 in the treatment of prostatic carcinoma. (1980) (12)
Long Term Survival in Advanced Urothelial Cancer with M-VAC: The First Two Years of Accrual (1987) (11)
Conservative approaches to the management of localized prostatic cancer (1993) (11)
Locoregional prostatic cancer.Advances in management (1990) (11)
Stage A prostatic cancer. (1986) (11)
Flow Cytometric Identification of Human Bladder Cells Using a Cytokeratin Monoclonal Antibody a (1986) (11)
Experiences with various operative procedures for the total excision of prostatic cancer. (1959) (11)
Detection of bladder carcinoma in females by flow cytometry and cytology. (1989) (11)
Renal function in dogs following transplantation of the ureters to an isolated sigmoid pouch. (1957) (10)
Lymphoscintigraphic Studies of Lymphatic Drainage from the Testes (1986) (10)
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology. (1987) (10)
Steroid hormone metabolites before and after orchiectomy for prostatic cancer. (1963) (10)
Serum Tumor Markers in Patients With Metastatic Germ Cell Tumors of the Testis (1984) (10)
VAB-3 combination chemotherapy in primary mediastinal germ cell tumors. (1982) (10)
Bladder cancer in men and women treated by radiation therapy and/or radical cystectomy. (1981) (10)
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. (1993) (10)
Bladder cancer: defining the clinical problem. (1984) (10)
BACK TO THE FUTURE-THE ROLE OF COMPLEMENTARY MEDICINE IN UROLOGY (1999) (9)
Impact of Transurethral Resection on the Long-Term Outcome of Patients with Prostatic Carcinoma (1993) (9)
The relation between the zinc content of the canine prostate and the histologic effects of dithizone. (1962) (9)
Interstitial irradiation using I-125 seeds. (1987) (9)
Ureteropyeloscopy: the diagnostic and therapeutic approach to upper tract urothelial tumors (1985) (9)
Preparation of Para-Aminobenzoic Acid Esters of Monoalkylamino Alcohols (1937) (9)
Irradiation and/or surgery. Some areas of confrontation in urologic oncology. (1984) (8)
The importance of accurate pathological classification in the prognosis of renal tumors; second report. (1949) (8)
Clinical significance of biologic markers: Memorial Hospital experience. (1979) (8)
Leydig cell tumors of testis including cryptorchid testis. (1972) (8)
Some effects of inhibitors of polyamine synthesis on experimental prostatic cancer. (1984) (8)
Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma. (1988) (8)
Newer diagnostic techniques for bladder cancer. (1987) (8)
Preparation of Ethylenesulfonic Acid—Salts and Esters (1946) (8)
How to perform transperineal saturation prostate biopsy (2003) (8)
Radiation therapy before cystectomy in the management of patients with bladder cancer. (1982) (8)
Special article: summary of all phases of bladder carcinoma. (1978) (7)
The effects of certain metals and chelating agents on the motility of dog epididymal and ejaculated spermatozoa. (1967) (7)
A fiberoptic ultraviolet cystoscope. (1967) (7)
The effect of chemotherapy on germinal testicular tumors in mice (1970) (7)
The effect of the presence of other elements on some microscopic tests for the metals (1930) (7)
Inferior pubic rami resection with en bloc radical excision for invasive proximal urethral carcinoma. (1983) (7)
Effects of estrogen administration on serum testosterone in copenhagen rats (1982) (7)
Application of Microscopic Analysis to Mixtures of Metals and Alloys (1930) (7)
Renal cell carcinoma. Overview. (1989) (7)
RNA and DNA content of isolated nuclei from bladder irrigation specimens as measured by flow cytometry. (1984) (6)
Consideration for treatment of upper urinary tract tumors with topical therapy. (1986) (6)
Retroperitoneal lymphadenectomy for germ cell tumor of testis in association with horseshoe kidney. (1981) (6)
Epidemiology of cancer of the prostate. (1971) (6)
Father-son testicular (teratocarcinoma) malignancy. (1983) (6)
Clinical Downstaging After Neo-Adjuvant M-VAC for Transitional Cell Carcinoma of the Urothelium (1987) (6)
Distinguishing prognostic and treatment-predictive information for localized prostate cancer. (1995) (6)
Update in Staging Systems (1987) (6)
Regional lymph node reactivity in explanted bladder cancer of mice as measured by flow cytometry. (1979) (6)
Ten thousand or more rads supervoltage irradiation to the bladder: efficacy, sequelae and management. (1972) (5)
The Thermal Polymerization of Monoölefinic Compounds1 (1950) (5)
A technique of ilioinguinal lymph node dissection for carcinoma of the penis. (1984) (5)
Bypass graft for femoral artery involvement by metastatic carcinoma of the penis. (1982) (5)
External beam versus brachy therapy in localized prostatic cancer (1984) (5)
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium. (1988) (5)
Simple total cystectomy for carcinoma of the urinary bladder; one hundred fifty-six consecutive cases five years later. (1956) (5)
A randomized, blinded study comparing microwave thermotherapy (dornier urowave(tm)) with a sham procedure in patients with clinical benign prostatic hyperplasia (bph) (1997) (5)
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function. (1978) (5)
Metabolism of 3H-estradiol in men with prostate cancer. (1980) (5)
Chemotherapy for bladder cancer. (1985) (4)
STUDIES IN PROSTATE CANCER BEFORE AND AFTER ORCHIECTOMY. (1963) (4)
Clinical Management of Prostatic Cancer An Overview (1988) (4)
Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell beta-glucuronidase activity. (1976) (4)
Adrenalectomy in the treatment of prostatic cancer. (1954) (4)
Cystoileostomy as a means of urinary stream diversion in dogs with a prostatic fistula. (1959) (4)
Wait and see: experience with B1 lesions. (1987) (4)
Nature and constitution of Shellac: IV. A study of the saponification number (1932) (4)
Simple cystectomy for cancer of the urinary bladder; 100 consecutive cases; 2 years later. (1950) (4)
Panniculectomy in conjunction with radical cystectomy in the obese patient. (1983) (4)
Mini-dose heparin therapy in pelvic lymphadenectomy and 125I implantation for localized prostatic cancer. (1980) (4)
COMMENTS ON ZINC IN THE HUMAN AND CANINE PROSTATES. (1963) (4)
Microscopic identification of some important substituted naphthalenesulfonic acids (1938) (4)
Surgical treatment of clinical stage I nonseminomatous germ gell tumors of the testis. (1982) (3)
Surgical management of low stage bladder cancer. (1979) (3)
Current therapy of bladder cancer. (1990) (3)
Adenocarcinoma of the kidney. (1955) (3)
State of the art: Summary and commentary (1984) (3)
Original Articles LONG-TERM RESULTS OF RETROPUBIC PERMANENT I2"IODINE IMPLANTATION OF THE PROSTATE FOR CLINICALLY LOCALIZED PROSTATIC CANCER (1997) (3)
Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder. (1978) (3)
Predicting the metastatic potential of prostatic cancer: Is lymph node staging necessary? (1987) (3)
The association of benign bladder papilloma with cancers of sites other than the bladder and ureter. (1970) (3)
Radiation Therapy for Prostatic Cancer (1984) (3)
The significance of retroperitoneal lymph node morphology in testicular tumours. (1977) (3)
Re: Adult Teratoma of the Testis Metastasizing as Adult Teratoma: Case Report and Review of Literature, by Kailash Kedia and Elwin E. Fraley, J. Urol., 114: 636–639, 1975 (1976) (2)
[The treatment of invasive cancers of the bladder]. (1988) (2)
RETROPUBIC IMPLANTATION OF $sup 125$I IN THE TREATMENT OF PROSTATIC CANCER. (1972) (2)
Managing prostate disorders in middle age and beyond. (1987) (2)
Background for screening: natural history and treatment. (1988) (2)
A device for the management of cutaneous ureterostomy. (1955) (2)
Afferent lymphatics: their importance to immunologically privileged sites. (1975) (2)
Androgen stimulated chemotherapy in the dunning R-3327 prostatic adenocarcinoma (2004) (2)
Experimental Chemotherapy in a Transplantable Renal Adenocarcinoma (1983) (2)
Lymph node reactivity to experimental bladder tumor in preimmunized animals as measured by two parameter flow cytometry. (1979) (2)
Transparent Emulsions of Some Essential Oils (1929) (2)
The use of spermatic cord lymphatics in the relief of surgically created lower extremity edema. A preliminary report of experiments in dogs. (1976) (2)
Role of Etoposide-Based Chemotherapy in the Treatment of Patients With Refractory or Relapsing Germ Cell Tumors (1985) (2)
Rectal invasion by benign prostatic hyperplasia. (1977) (2)
Additive effects of dithizone and oxine on the canine prostate. (1962) (2)
The diagnosis of renal neoplasms. (1953) (2)
Selection of treatment for muscle infiltrating transitional cell bladder cancer. (1990) (2)
Mercury‐induced necrosis of murine renal cell carcinoma (1981) (1)
A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors (1989) (1)
Transrectal prostatic resection. (1972) (1)
Long‐term effects of initial therapy (1987) (1)
Surgical techniques in invasive bladder cancer. (1986) (1)
CANCER DETECTION IN OFFICE PRACTICE. (1964) (1)
Intravenous cisplatin for superficial bladder tumors. (1983) (1)
Panel Discussion: Management of Stages A1 and A2 Disease (1988) (1)
A technique of urethrectomy in the male. (1970) (1)
Ultraviolet cystoscopy. (1968) (1)
Radical cystectomy with or without planned preoperative irradiation in the treatment of bladder cancer (2004) (1)
Mercury-Induced Necrosis of Murine Renal Cell Carcinoma (1982) (1)
Interstitial I-125 implantation in the management of localized prostatic cancer. (1984) (1)
Estrogen binding and estrogen receptor activity in the human prostate: a preliminary report. (1981) (1)
Bladder cancer in men and women treated by radiation therapy and/or radical cystectomy (1981) (1)
Urinary diversion. A continuing challenge. (1989) (1)
Multidisciplinary challenge of pheochromocytoma. (1971) (1)
Preoperative irradiation with cystectomy for bladder cancer. (1984) (1)
PANEL DISCUSSION ON THE CLINICAL MANAGEMENT OF PROSTATIC DISEASE † (1959) (1)
Gallium and bleomycin scans in the clinical staging of testis tumor. (1978) (1)
Re: Management of recurrent urinary stress incontinence by the Marshall-Marchetti-Krantz vesicourethropexy. (1985) (1)
Observations on serum enzyme alterations in experimental renal ischemia. (1973) (1)
Benign prostatic hyperplasia: widespread and sometimes worrisome. (1981) (1)
Consensus Development Conference on the Management of Clinically Localized Prostate Cancer. Overview: historical and contemporary. (1988) (1)
ULTRAVIOLET TETRACYCLINE FLUORESCENCE OF URINARY SEDIMENTS. (1965) (1)
Testicular Masses: Progress in Diagnosis and Treatment (1980) (1)
Preoperative irradiation combined with cystectomy in the treatment of bladder cancer. (1964) (1)
Cystectomy + diversion for carcinoma of the bilharzial bladder. (1988) (1)
Carcinoma of the Penis (1983) (1)
Effects of intermittent estrogen administration on the R3327H rat prostatic carcinoma (1986) (1)
Presumptive Downstaging From Preoperative Irradiation for Bladder Cancer as Determined by Flow Cytometry: Preliminary Report (1983) (1)
Chemotherapy in the Management of Bladder Tumours (1989) (1)
The evolution of urologic oncology: a personal perspective. (1990) (0)
Experience with simple cystectomy in the treatment of carcinoma of the bladder. (1954) (0)
Prostate Cancer — Natural History and Staging (1983) (0)
Retroperitoneal angiomyosarcoma: a case report. (1971) (0)
Obstruction of the rectosigmoid and sigmoid flexure after radical cystectomy for cancer of the bladder (1967) (0)
Modified Ilioinguinal Node Dissection for Penile and Urethral Cancer (1987) (0)
Effects of Intermittent Diet hvIstÃ 1⁄4 bestrol Diphosphate Administration on the R 3327 Rat Prostatic Carcinoma (2006) (0)
RADIOTHERAPY: MODALITIES AND USES. (1964) (0)
CARCINOMATOUS POLYNEUROMYOPATHY. (1964) (0)
Radiotherapeutic management of testicular cancer in older age (1977) (0)
The Preparation and Properties of Aliphatic Esters of Erythrol (1949) (0)
Pre-operative irradiation combined with cystectomy in the management of bladder cancer. (1972) (0)
Therapy and prognosis of testicular carcinomas (1981) (0)
Patterns of recurrence in testicular carcinomas treated by irradiation and/or lymphadenectomy and chemotherapy (1981) (0)
Some observations on the neurogenic bladder. (1948) (0)
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy. (1988) (0)
Specificity analysis of mouse mono4 surface antigens of human renal ca (differentiation antigens/immunopathology/adenosine deaminase bin (2016) (0)
Radiation therapy in germinal tumors of the testis (1978) (0)
Germinal tumors of the testis. (1970) (0)
Proceedings: Germinal testis tumors in adults. (1972) (0)
‘Local Recurrence’ and ‘Disease-Free Survival’ (1991) (0)
TUMOR CLINIC CONFERENCE. (1964) (0)
Therapy and prognosis of testicular cancer (1979) (0)
Accumulation of D- vs. L-isomers of alanine and leucine in rat prostatic adenocarcinoma (1985) (0)
Studies of lymphatic drainage from testes by lymphoscintigraphy (1985) (0)
The use of progesterone in treatment of cancer of the prostate. (1951) (0)
THE TREATMENT OF METASTATIC PROSTATIC CANCER WITH DITHIZONE (DIPHENYLTHIOCARBAZONE). (1963) (0)
THE RESULTS OF RADICAL SURGERY FOR THE TREATMETN OF CANCER OF THE BLADDER (1962) (0)
Observations on serum enzyme alterations in experimental renal ischemia. (1973) (0)
Management of flat carcinoma in situ of the bladder. (1984) (0)
Letter to the editor: Adult teratoma of the testis metastasizing as adult teratoma: case report and review of literature. (1976) (0)
Recent advances in the management of genitourinary neoplasms. (1991) (0)
Flow cytometric identification of human bladder cells using a cytokeratin monoclonal antibody. (1987) (0)
The Forty‐Ninth Janeway Lecturer (1984) (0)
CANCER COMMENTS FROM POLAND AND THAILAND. (1964) (0)
Non-seminomatous germ cell testis tumors--how do you manage clinical state IIA? (1985) (0)
Invited commentary (1980) (0)
Early diagnosis of cancer of the male genitourinary organs. (1959) (0)
Some present concepts of carcinogenesis; bladder carcinoma. (1959) (0)
Total cystectomy. (1948) (0)
Retropubic implantation of I125 in the treatment of prostatic cancer. (1976) (0)
Renal Cell Carcinomas Specific Region of the Human Proximal Tubule and Subsets Analysis of a Mouse Monoclonal Antibody That Reacts with a Updated (2006) (0)
Support de sonde a ultrasons et dispositif de progression (1998) (0)
Chemotherapy and trace element levels in blood and tissue of rats implanted with prostate tumor cells (1985) (0)
Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy. (1967) (0)
To the editor (2006) (0)
Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. (1962) (0)
Preoperative irradiation with cystectomy for bladder cancer. (1984) (0)
Characterization of BladderPapillomabyTwo-ParameterDNA-RNAFlow Cytometry' (1982) (0)
Phase I/II trial of intravesical methotrexate for superficial bladder tumors (2004) (0)
The management of cutaneous ureterostomies (1952) (0)
The diagnosis of genitourinary neoplasms. (1960) (0)
SURGICAL TREATMENT OF BLADDER NEOPLASMS. (1963) (0)
Treatment of testis neoplasms. (1960) (0)
The rate of skin allografts within the prostate. (1976) (0)
Retropubic implantation of iodine 125 in the treatment of prostatic cancer. 1972. (2002) (0)
Human renal cancer cell surface antigens defined by mouse monoclon- al antibodies. Abstr. (1981) (0)
Contents, Vol. 47, Supplement 1, 1991 (1991) (0)
Diagnostic and therapeutic significance of retroperitoneal lymph node dissection in low stage and localized disease: point of view. (1985) (0)
CANCER DEFINED BY AUTOLOGOUS TYPING (1979) (0)
Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center. (1985) (0)
Ureteral stent with small bladder ends (1996) (0)
Pubic rami resection for urologic cancer. (1982) (0)
Urethral Stent with small bladder end (1996) (0)
Bladder cancer with and without stage reduction on cystectomy after irradiation (1980) (0)
Intravenous cisplatin for superficial bladder tumors (0)
The use of testicular lymphatics to bypass obstructed lymphatics in the dog. (1981) (0)
Bladder cancer (1978) (0)
Irradiation and/or surgery (1984) (0)
Iodine-125 re-implant in recurrent prostatic cancer (1984) (0)
Testicular cancer associated with prior or current crystorchidism (1977) (0)
Factors of prognostic and therapeutic significance in bladder cancer (1977) (0)
Introduction: Locally invasive tumors: Treatment (1984) (0)
Radiation therapy of testicular cancer in younger age (1977) (0)
Effects of a-Difluoromethylornithine and Methylglyoxal Bis(guanylhydrazone) on the Growth of Experimental Renal Adenocarcinoma in Mice1 (2006) (0)
Introduction to the Microtechnique of Inorganic Analysis (Benedetti-Pichler, A. A.) (1943) (0)
Experimental chemotherapy in a transplantable renal adenocarcinoma. I: Effects of some inhibitors of polyamine synthesis. (1983) (0)
Indications for systematic urethrectomy. (1984) (0)
Author's Reply: Feedback (1978) (0)
Systematic organic analysis (1930) (0)
Urothelial tumor: problems and prospects. (1983) (0)
Expectant management of clinically localized prostatic cancer. (1994) (0)
Correlation of PSA with long term outcome in patients treated for prostatic carcinoma (1993) (0)
HYPERCALCEMIA AND HYPOGLYCEMIA. (1964) (0)
Some aspects of clearance of mitoguazone in cancer patients and experimental cancer models. (1986) (0)
Testicular cancer according to age (1978) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Willet F. Jr. Whitmore?

Willet F. Jr. Whitmore is affiliated with the following schools:

Willet F. Jr. Whitmore's Academic­Influence.com Rankings

Willet F. Jr. Whitmore's Degrees

Why Is Willet F. Jr. Whitmore Influential?

Willet F. Jr. Whitmore's Published Works

Published Works

What Schools Are Affiliated With Willet F. Jr. Whitmore?

Willet F. Jr. Whitmore's AcademicInfluence.com Rankings